New Delhi, Dec 24 (IANS) A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).The team from the University of California-Davis, US, tested an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug and found it to be safe and potentially effective in patients with PSC.Published in the American Journal of Gastroenterology, the results offer encouraging news for patients with PSC, for which there are…
Trending
- Alvida: The Last Goodbye Review — A Haunting Farewell That Lingers Long After the Credits
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard
- Licence Review (2026): Masoom Sharma Delivers a Gripping Haryanvi Crime Drama
- Bhagubai (2026) Review: Nirmiti Sawant Shines in This Heartfelt Marathi Village Drama
- Ginny Wedss Sunny 2 Review (2026): A Warm and Relatable Ride Through the Chaos of Arranged Marriage
- Jerax Review (2026): Nagabhushan’s Supernatural Thriller Is a Wildly Entertaining Ride
- Battle (2026) Movie Review — Tamil Rap Drama Finds Its Rhythm in Flashes